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Investigating the role of Nrg1p and Tup1p during Candida albicans
Chlamydospore Formation
Introduction

Shannon M. Williams
McNair Scholar

Candida albicans exists and thrives
on mucosal surfaces of the gastrointestinal
tract and urogenital tract in healthy
persons, but it can also cause severe and
life-threatening infections, especially
in immunocompromised patients (4),
and thus has become a relevant topic in
the medical community. A wide range
of factors leads to various degrees of
immunosuppression
that
predispose
patients to infection by Candida. These
factors include a severe underlying disease
(e.g., AIDS or leukaemia), impaired
phagocytic function (i.e., granulocytopenia
or neutropenia), and exogenous factors
(e.g., wide spectrum antibiotic treatment,
i.v. drug use, transplantation medicine,
trauma, abdominal surgery [5]). Also,
candidiasis, a systemic yeast infection,
now represents the third to fourth most
frequent hospital acquired infection in
the US and worldwide, and C. albicans
remains the most frequent causative
agent of candidiasis (1). These infections
carry unacceptably high morbidity and

mortality rates and important economic
repercussions with an estimated total
direct cost of approximately 2 billion
dollars in 1998 in US hospitals alone (14).
Even treatments using available antifungal
agents, mortality rates lie in the 30-50%
range for these infected patients (13).
Although several other Candida species
are also human pathogens that have
been found with increasing frequency, C.
albicans remains by far the most medically
important member of the genus (7).
C. albicans can transition between
yeast cells, psuedohyphae or hyphae.
Filamentation of yeast cells to hyphal
growth is directly linked to its pathogenicity
and cells that cannot make the transition
are known to be avirulent. C. albicans is
known to form chlamydospores when
low levels of nutrients comprise its
environment. Chlamydospores are thickwalled, spherical cells that are three to
four times larger than normal yeast cells
and are produced from suspensor cells at
the end of what are likely pseudohyphal
elements ([10] Figure 1).
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Figure 1: Chlamydospore formation of C. albicans
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Because chlamydospores arise in
conditions of nutrient depletion, they are
believed to be dormant growth forms that
can be induced to germinate by changing
environmental conditions (6).
Chlamydospore-like structures have
been detected occasionally in the human
host, however, whether chlamydospores
contribute to colonization or pathogenicity
of C. albicans is unknown (4). Examining
the regulation of the gene NRG1p and its
direct relationship to filamentation (hyphal
growth) and chlamydospore formation, will
contribute greatly to the understanding of
this virulence factor of C. albicans and
what its biological role is. This study aims
to fill in the gaps in our understanding
of the mechanisms which underpin this
important biological phenomenon, the
genetic regulation of chlamydospore
formation in relation to filament formation.
The gene NRG1 is a known inhibitor, or
repressor, of the Hyphal Specific Genes
(HSG) and has been strongly implicated
in chlamydospore formation. It has
been shown that differential regulation
of the single gene NRG1 in C. albicans
and (closely related species) Candida
dubliniensis is responsible for their speciesspecific response to environmental signals
that induce chlamydospore development
(12). Furthermore, morphogenesis (yeast
to psuedohyphal/hyphal transition) is
repressed by transcriptional inhibitors such
as Tup1p, which associates with its DNAbinding partners NRG1p and Rfg1p (3).
However, the nature by which this gene is
regulated is in question; thus, in this study
we intended to investigate (1) the hyphal
specific genes regulated in chlamydospore
formation and (2) the necessity or
dependency of coupling with the gene
TUP1 during chlamydospore formation.

ICY49 (∆tup1/∆tup1).
Culture media and growth
conditions for preparation of
RNA analysis. All strains were grown
overnight in liquid YPD (yeast, peptone,
dextrose media) at 28ºC. Cultures were
then washed with phosphate buffered
NaCl (PBS) x 2 (as described by Jansons
and Nickerson, [6]). Various dilutions of
each strain yeilded a cell count of 10¬¬6/
mL. A 20:1 diluted subculture of each
strain was added to liquid Staib media
(syn. Guizotia abyssinica, creatinine,
glucose, KH2PO4¬), (12). In addition, two
subcultures of DPTY2 and SSY50b were
made, one with the tetracycline analog,
doxycycline, and the other without. These
cultures were then grown at 32ºC for 48
hours in a shaking water bath.
RNA isolation was achieved with our
adapted methodology and the Masterpure
yeast isolation kit (Epicentre™). 1µg of this
RNA was used to generate cDNA using the
first strand synthesis kit (Five-prime™), and
the cDNA was quantitatively compared
by real-time PCR using GoTaq™ Sybr™
green (Promega™) on an Mx3000P realtime machine (Stratagene™). The relative
expression of the ACT1 (actin) gene was
used to normalize the data across samples.
Culture media and growth
conditions
for
NRG1/Tup1
association assay. Initial steps up to
and including PBS wash were the same as
above. Each strain was inoculated to plates
of Staib agar, with and without doxycycline
and Rice Tween 80 agar (RTW), with
and without doxycycline. RTW plates
were housed in a candle jar. Plates were
incubated at 28ºC, in darkness, for 14 days.
Cultures were analyzed by microscopy at
48 hours, 7 days and 14 days.

Materials and Methods

Results

Strains. A comparison of four C.
albicans strains and one C. dubliniensis
strain were used. C. albicans wild-type
strain SC5314 was used as a control along
with C. dubliniensis wild-type strain.
These strains were chosen based on their
known performance in Staib medium, as
published by Staib and Morschhäuser.
Comparison strains used were C. albicans
strains DPTY2 (NRG1/NRG1 tet-NRG1),
SSY50b (∆NRG1/NRG1 tet-NRG1), and

Analysis of genetic expression
of Hyphal Specific Genes in tetregulated NRG1 strains. Quantitative
real-time PCR analysis of DPTY2 and
SSY50b, with and without doxycycline,
reveals a difference in expression of
the major hyphal-specific genes on
chlamydospore formation. This data
shows that when complete repression of
NRG1 (DPTY2) occurs within the first
48hrs, the major hyphal-specific genes are

affected differently from the filamentation
pathway, as seen by the control effects of
SSY50b (Fig. 2).
Analysis of dependency of NRG1
in chlamydospore formation. In
order to determine whether the association
of NRG1p and Tup1p is involved in the
development of chlamydospores in C.
albicans, we used two types of media.
Using staib agar, which is known to stifle
chlamysdospore formation in C. albicans
but not in C. dubliniensis, we created one
plate with the addition of doxycycline and
the other plate without. Since comparisons
of C. albicans and C. dubliniensis have been
found to regulate NRG1p differently (12),
we took advantage of the wild-type strains
SC5314 (C. albicans) and C. dubliniensis
as controls to our variable strains DPTY2
(∆NRG1/tet-NRG1), SSY50b (NRG1/
tet-NRG1) and ICY49 (∆Tup1/∆Tup1).
Another way we controlled the experiment
was to use a nutrient-poor media, Rice
Tween 80 agar, in a candle jar to limit
the oxygen availibility, which supports
chlamydospore formation in C. albicans.
The RTW plates were made with and
without doxycycline.
Each strain was innoculated onto the
plain Staib and RTW plates, with the tetregulateable strains DPTY2 and SSY50b
added to the doxycycline plates. All
cultures were grown at 28ºC in darkness
for 14 days. Comparison assessments were
documented via microscopy at 48 hours, 7
days and 14 days (Fig. 3).
In the Staib agar, we were able to
induce chlamydospore formation in C.
albicans that is indistinguishable from
the C. dubliniensis wild-type. However,
for SSY50b, which has one regulateable
allele of NRG1 and one wild-type allele,
we were unable to induce chlamydospore
formation. SSY50b acts the same as
SC5314 (wild-type), which grows a neglible
amount of chlamydospores (1-5% 10µL-1).
This data shows that expression of NRG1
has a significant negative repression on
chlamydospore formation in C. albicans,
and when it is inhibited, chlamydospore
formation is induced.
If TUP1 is a crucial binding partner
to NRG1 to induce chlamydospore
formation, deleting the gene should show
similar results to the complete repression
of NRG1. Our results show the contrary.
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When ICY49 is grown in the same
conditions described above on Rice Tween
80 agar plus doxycycline, chlamydospore
formation is no more significant than the
wild-type expression of SC5314. This
leads to the conclusion that TUP1 is not
a significant participant in chlamydospore
formation. Further investigations will focus
on if NRG1 alone regulates chlamydospore
formation or if it binds with any other gene
during this regulation.

Figure 2: Differential expression of hyphal specific genes on NRG1p
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